PT  - JOURNAL ARTICLE
AU  - Moser, Justin C
AU  - Alistar, Angela
AU  - Cohen, Ezra
AU  - Garmey, Edward
AU  - Kazmi, Syed
AU  - Mooneyham, Teresa
AU  - Sun, Lijun
AU  - Yap, Timothy
AU  - Mahalingam, Devalingam
TI  - 618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L)1 checkpoint inhibitors
AID  - 10.1136/jitc-2023-SITC2023.0618
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A704--A704
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A704.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A704.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.